Andrea Pace,Veronica Villani,Antonella Di Pasquale et al.
Andrea Pace et al.
Background: Brain tumor patients are quite different from other populations of cancer patients due to the complexity of supportive care needs, the trajectory of disease, the very short life expectancy, and resulting need ...
Integration of palliative care into the neuro-oncology practice: patterns in the United States [0.03%]
姑息治疗融入神经肿瘤临床实践:美国的现状
Tobias Walbert
Tobias Walbert
Background: Between 80%-85 percent of all adult brain tumors are high-grade gliomas (HGGs). Despite aggressive treatment with surgical resection, radiotherapy and chemotherapy, the survival of patients with HGG is limited...
Susan M Chang Md
Susan M Chang Md
Work productivity and neuropsychological function in persons with skull base tumors [0.03%]
颅底肿瘤患者的劳动生产率和神经心理功能
Bethany D Nugent,Jason Weimer,Chienwen J Choi et al.
Bethany D Nugent et al.
Background: Skull base tumors comprise many common benign brain tumors. Treatment has advanced, allowing many survivors to return to work. However, literature is limited about the neuropsychological status of these patien...
How do I prescribe and manage mIDH inhibitors in patients with IDH-mutant glioma? [0.03%]
如何在具有IDH突变的胶质瘤患者中开具和管理mIDH抑制剂?
Recent interest has been in using mIDH inhibitors in patients with IDH-mutant gliomas. This review paper summarizes the indications, side effects, recommended dosing, and management for patients on ivosidenib and vorasidenib. ...
"Aiming at a moving target"-The daily life experiences of adolescents and young adults with a low-grade glioma [0.03%]
“瞄准一个移动的目标”——低级别胶质瘤青少年和年轻成人患者的日常生活体验
Background: Low-grade gliomas (LGG) are among the most frequently occurring tumors in adolescent and young adult (AYA) patients (aged 18-39 years old at primary diagnosis). These tumors have a variable prognosis, presenti...
Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023 [0.03%]
从2016年到2023年,胶质母细胞瘤基因组检测的常规化为临床治疗带来的启示与思考
Background: In 2016, genomic profiling was implemented for patients with grade 4 primary brain tumors at Rigshospitalet, Denmark. The aim of this study was to discover actionable alterations and to match these with target...